Literature DB >> 26074146

Familial fatal insomnia with atypical clinical features in a patient with D178N mutation and homozygosity for Met at codon 129 of the prion protein gene.

Lin Sun1, Xia Li, Xiang Lin, Feng Yan, Kathryn Chen, Shifu Xiao.   

Abstract

Familial fatal insomnia (FFI) is fatal disorder characterized by damage to select thalamic nuclei, together with progressive insomnia and dysautonomia. In subjects carrying the D178N prion protein (PRNP) mutation, distinct phenotypes can be observed, depending on the methionine (Met) /valine (Val) codon 129 polymorphism. We report here a Chinese case of FFI with a D178N/Met129 genotype of the PRNP gene, who exhibited rapidly progressive dementia combined with behavioral disturbances and paroxysmal limb myoclonus. Our patient did not show refractory insomnia early in the disease course, nor demonstrate typical MRI and EEG alterations. There was remarkable family history of similar symptoms.

Entities:  

Keywords:  D178N; D178N, Asp178Asn; FFI, familial fatal insomnia; Familial fatal insomnia; Met 129, Methionine 129; Met129; PRNP, prion protein; prion protein

Mesh:

Substances:

Year:  2015        PMID: 26074146      PMCID: PMC4601199          DOI: 10.1080/19336896.2015.1054601

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  16 in total

1.  Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia.

Authors:  Y Taniwaki; H Hara; K Doh-Ura; I Murakami; H Tashiro; T Yamasaki; H Shigeto; K Arakawa; E Araki; T Yamada; T Iwaki; J Kira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

Review 2.  Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis.

Authors:  Sabina Capellari; Rosaria Strammiello; Daniela Saverioni; Hans Kretzschmar; Piero Parchi
Journal:  Acta Neuropathol       Date:  2010-10-27       Impact factor: 17.088

3.  Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei.

Authors:  E Lugaresi; R Medori; P Montagna; A Baruzzi; P Cortelli; A Lugaresi; P Tinuper; M Zucconi; P Gambetti
Journal:  N Engl J Med       Date:  1986-10-16       Impact factor: 91.245

4.  The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010.

Authors:  Chen Gao; Qi Shi; Chan Tian; Cao Chen; Jun Han; Wei Zhou; Bao-Yun Zhang; Hui-Ying Jiang; Jin Zhang; Xiao-Ping Dong
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

5.  Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.

Authors:  Adrian C Apetri; David L Vanik; Witold K Surewicz
Journal:  Biochemistry       Date:  2005-12-06       Impact factor: 3.162

6.  Phenotypic variability in familial prion diseases due to the D178N mutation.

Authors:  J J Zarranz; A Digon; B Atarés; A B Rodríguez-Martínez; A Arce; N Carrera; I Fernández-Manchola; M Fernández-Martínez; C Fernández-Maiztegui; I Forcadas; L Galdos; J C Gómez-Esteban; A Ibáñez; E Lezcano; A López de Munain; J F Martí-Massó; M M Mendibe; M Urtasun; J M Uterga; N Saracibar; F Velasco; M M de Pancorbo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

Review 7.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

8.  Phenotypic characteristics of familial Creutzfeldt-Jakob disease associated with the codon 178Asn PRNP mutation.

Authors:  P Brown; L G Goldfarb; J Kovanen; M Haltia; F Cathala; M Sulima; C J Gibbs; D C Gajdusek
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

9.  Fatal familial insomnia: Clinical features and early identification.

Authors:  Anna Krasnianski; Mario Bartl; Pascual J Sanchez Juan; Uta Heinemann; Bettina Meissner; Daniela Varges; Ulf Schulze-Sturm; Haus A Kretzschmar; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Ann Neurol       Date:  2008-05       Impact factor: 10.422

10.  A case of dementia with PRNP D178Ncis-129M and no insomnia.

Authors:  Rita J Guerreiro; Tina Vaskov; Cynthia Crews; Andrew Singleton; John Hardy
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

View more
  5 in total

1.  Clinical features and genetic characteristics of two Chinese pedigrees with fatal family insomnia.

Authors:  Runcheng He; Yacen Hu; Lingyan Yao; Yun Tian; Yafang Zhou; Fang Yi; Lin Zhou; Hongwei Xu; Qiying Sun
Journal:  Prion       Date:  2019-01       Impact factor: 3.931

2.  Corticobasal manifestations of Creutzfeldt-Jakob disease with D178N-homozygous 129M genotype.

Authors:  Yumeng Huang; Ma Jianfang; Rodrigo Morales; Huidong Tang
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

3.  Genetic Creutzfeldt-Jakob disease shows fatal family insomnia phenotype.

Authors:  Bin Chen; Shan Zhang; Ying Xiao; Yingman Wu; Weiting Tang; Limin Yan; Zhengxue Zhang; Shengquan Qin; Mingming Dai; Yong You
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

4.  Fatal familial insomnia presenting with agrypnia excitata and very low atonia index level: A case report and literature review.

Authors:  Tae-Won Yang; Byeongsu Park; Keun Tae Kim; Jin-Sun Jun; Young-Soo Kim; Soon-Tae Lee; Keun-Hwa Jung; Kon Chu; Sang Kun Lee; Ki-Young Jung
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

5.  Autoantibodies against the prion protein in individuals with PRNP mutations.

Authors:  Karl Frontzek; Manfredi Carta; Marco Losa; Mirka Epskamp; Georg Meisl; Alice Anane; Jean-Philippe Brandel; Ulrike Camenisch; Joaquín Castilla; Stéphane Haïk; Tuomas Knowles; Ewald Lindner; Andreas Lutterotti; Eric Vallabh Minikel; Ignazio Roiter; Jiri G Safar; Raquel Sanchez-Valle; Dana Žáková; Simone Hornemann; Adriano Aguzzi
Journal:  Neurology       Date:  2020-02-25       Impact factor: 11.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.